default author photo

Marco Galaverni

University Hospital of Parma

Parma

Italy

  • University Hospital of Parma

SCHOLARLY PAPERS

1

DOWNLOADS

29

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Locally Advanced Nsclc: Overview of Real-World Pattern of Recurrence in Durvalumab Era (Leopard Trial)

Number of pages: 17 Posted: 05 Jun 2025
Patrizia Ciammella, Federico Iori, Paolo Borghetti, Marco Galaverni, Emanuele Alì, Marcello Tiseo, Maria Pagano, Matteo Sepulcri, Vieri Scotti, Niccolò Giaj-Levra, Michela Marcenaro, Nicola Simoni, Andrea Botti, Valerio Nardone, Salvatore Cozzi and Alessio Bruni
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Ospedale Sacro Cuore Don Calabria, affiliation not provided to SSRN, University Hospital of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland and affiliation not provided to SSRN
Downloads 29 (1,359,097)

Abstract:

Loading...

non-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy, salvage therapy, SBRT, PACIFICnon-small cell lung cancer, radiotherapy, durvalumab, oligorecurrence, recurrence pattern, chemoradiotherapy